Rituximab versus the modified Ponticelli regimen in the treatment of primary membranous nephropathy: a Health Economic Model. (2018)
Attributed to:
Understanding the autoimmune mechanism in idiopathic membranous nephropathy (IMN)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ndt/gfy049
PubMed Identifier: 29617884
Publication URI: http://europepmc.org/abstract/MED/29617884
Type: Journal Article/Review
Volume: 33
Parent Publication: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Issue: 12
ISSN: 0931-0509